List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 417 studies with search of: Open Studies | "Platelet Aggregation Inhibitors"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Rapid Activity of Platelet Inhibitor Drugs Study
Condition: ST-segment Elevation Myocardial Infarction
Interventions: Drug: Prasugrel;   Drug: Ticagrelor
2 Recruiting Cardiovascular Magnetic Resonance for the Occluded Infarct-Related Artery Treatment
Conditions: Cardiovascular Diseases;   Heart Diseases;   Myocardial Infarction;   Heart Failure
Interventions: Drug: Beta adrenergic blockers;   Drug: Platelet inhibitors;   Drug: Statins;   Drug: ACE inhibitors and/or ARB and/or AA;   Procedure: PCI with stenting
3 Recruiting Study of LC23-1306 in Healthy Male Subjects
Condition: Acute Coronary Syndrome
Interventions: Drug: LC23-1306;   Drug: placebo;   Drug: Ticagrelor
4 Unknown  Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay
Condition: 30 Healthy People
Intervention: Drug: Clopidogrel and proton pump inhibitors
5 Recruiting Platelet Transfusion in Acute Intracerebral Hemorrhage
Condition: Intracerebral Hemorrhage
Intervention: Biological: platelets
6 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
7 Unknown  PACT (Platelet Activity After Clopidogrel Termination)
Conditions: Blood Platelets;   Clopidogrel
Interventions: Drug: clopidogrel + aspirin;   Drug: placebo + aspirin
8 Recruiting Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients
Condition: Coronary Artery Disease
Intervention: Drug: Clopidogrel
9 Recruiting Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Conditions: Cardiovascular Diseases;   Acute Coronary Syndrome
Interventions: Drug: clopidogrel;   Drug: prasugrel
10 Recruiting Pharmacokinetic Assessment of Simultaneous Administration of Clopidogrel and Aspirin
Condition: Coronary Artery Disease
Interventions: Drug: Cloas;   Drug: Plavix/Astrix
11 Unknown  The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
Conditions: Hypercholesterolemia;   Thrombosis
Interventions: Drug: Clopidogrel;   Drug: Atorvastatin
12 Recruiting Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)
Conditions: Coronary Artery Disease;   Coronary Thrombosis
Intervention: Device: Medtronic Endeavor Stent
13 Recruiting Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery
Conditions: Coronary Artery Bypass Graft Triple Vessel;   Blood Coagulation Disorders
Intervention:
14 Recruiting Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Condition: Coronary Artery Disease
Interventions: Drug: Prasugrel Loading Dose;   Drug: Prasugrel Maintenance Dose;   Drug: Ticagrelor Maintenance Dose
15 Recruiting Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)
Condition: Percutaneous Coronary Intervention
Intervention: Drug: omega 3
16 Recruiting A Study on the Effect of Cilostazol in Patients With Chronic Tinnitus
Condition: Tinnitus
Interventions: Drug: Cilostazol;   Drug: Placebo
17 Unknown  Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
Conditions: Coronary Artery Disease;   Myocardial Ischemia;   Bleeding
Intervention: Drug: clopidogrel 600 mg
18 Recruiting Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27
Conditions: Cardiovascular Disease;   Overweight
Intervention: Drug: clopidogrel
19 Recruiting Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction.
Condition: Anti Platelet Effects
Interventions: Drug: Clopidogrel;   Drug: Prasugrel;   Drug: Lansoprazole;   Drug: Placebo
20 Recruiting Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
Conditions: Myocardial Infarction;   Acute Coronary Syndromes;   Unstable Angina
Interventions: Drug: Tirofiban;   Drug: Eptifibatide

Previous Page Studies Shown (1-20) Next Page (21-40)
Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options